WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Martine A. RothblattCEO;Chair2026-11-123,079$594.24
$1.83MSell
Martine A. RothblattCEO;Chair2026-11-12323$588.30
$190.02kSell
Martine A. RothblattCEO;Chair2026-11-12159$587.00
$93.33kSell
Martine A. RothblattCEO;Chair2026-11-129,500$117.76
$1.12MBuy
Martine A. RothblattCEO;Chair2026-11-121,934$593.44
$1.15MSell
Martine A. RothblattCEO;Chair2026-11-12551$592.32
$326.37kSell
Martine A. RothblattCEO;Chair2026-11-12317$591.10
$187.38kSell
Martine A. RothblattCEO;Chair2026-11-12359$590.11
$211.85kSell
Martine A. RothblattCEO;Chair2026-11-12427$589.21
$251.59kSell
Martine A. RothblattCEO;Chair2026-11-121,409$595.17
$838.59kSell

1 of 323

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lilly Co Eli12.33%5,251,394$3.10BInsider
Martine A. Rothblatt2.08%885,463$523.46MInsider
Paul A. Mahon0.11%45,172$26.70MInsider
Tommy G. Thompson0.09%36,480$21.57MInsider
Roger Jeffs0.06%27,259$16.11MInsider
Richard Giltner0.05%21,884$12.94MInsider
Michael Benkowitz0.05%21,756$12.86MInsider
James Edgemond0.04%18,876$11.16MInsider
Ray Kurzweil0.03%13,320$7.87MInsider
Nilda Mesa0.01%5,580$3.30MInsider

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR0.07%14.93%Net SellingNet Selling
INCY0.06%27.95%Net SellingNet Selling
INSM0.06%17.31%Net SellingNet Selling
ALNY0.08%20.80%Net SellingNet Buying
ROIV0.05%91.61%Net SellingNet Selling
View Top Biotech Stocks

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 0.07% institutional shareholders, 14.93% United Therapeutics insiders, and 85.01% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 12.33% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $3.10B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.